|
Status |
Public on Oct 01, 2006 |
Title |
skin_nonlesional atopic dermatitis skin_NLAD1 (U133B) |
Sample type |
RNA |
|
|
Source name |
skin(dermis and epidermis)_upper arm
|
Organism |
Homo sapiens |
Characteristics |
Tissue:skin(dermis and epidermis)_Source:upper arm_Health status:atopic dermatitis_Disease Severity:severe_Skin status:nonlesional_Age:44years_Gender:female_Race:black
|
Treatment protocol |
see Materials and Methods section of DA Plager, AA Leontovich, et al. Experimental Dermatology 2006 article; all therapeutic treatments or confounding exposures were avoided
|
Growth protocol |
Not applicable
|
Extracted molecule |
total RNA |
Extraction protocol |
see Materials and Methods section of DA Plager, AA Leontovich, et al. Experimental Dermatology 2006 article; Trizol extraction of total RNA followed by RNeasy clean-up of total RNA was performed according to the manufacturers' instructions.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 8 micrograms total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).
|
|
|
Hybridization protocol |
Following fragmentation, cRNA was hybridized overnight at 45C on Affymetrix Human Genome U133B GeneChip. GeneChips were washed and stained with phycoerythrin-labelled streptavidin in the Affymetrix Fluidics Station.
|
Scan protocol |
GeneChips were scanned using the Affymetrix GeneArray Scanner.
|
Description |
no additional information
|
Data processing |
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) to quantify and scale the fluorescence data.
|
|
|
Submission date |
Aug 29, 2006 |
Last update date |
Aug 29, 2006 |
Contact name |
Douglas A Plager |
E-mail(s) |
[email protected]
|
Organization name |
Mayo Clinic Rochester
|
Department |
Dermatology
|
Street address |
200 First Street SW
|
City |
Rochester |
State/province |
MN |
ZIP/Postal code |
55905 |
Country |
USA |
|
|
Platform ID |
GPL97 |
Series (1) |
GSE5667 |
Transcription data from Normal Skin and Nonlesional and Lesional Atopic Dermatitis/Eczema Skin |
|